The absolute conviction of IL11′s anti-inflammatory activity is apparent from clinical trials in which rhIL11 was administered to patients with hepatitis, colitis, rheumatoid arthritis and other conditions [12]. This evidence concerns the gene IL11 and rheumatoid arthritis.